XML 69 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value (Tables)
6 Months Ended
Jun. 30, 2013
Fair Value [Abstract]  
Fair value of assets and liabilities measured on a recurring basis
The following tables summarize the valuation of our financial instruments by pricing observability levels as of June 30, 2013 and December 31, 2012:

 
 
June 30, 2013
 
 
 
Level 1
  
Level 2
  
Level 3
  
Total
 
 
 
(in thousands)
 
 
        
Money markets
 
$
275,458
  
$
  
$
  
$
275,458
 
U.S. Treasury Bills
  
   
824,061
   
   
824,061
 
U.K. Treasury Bills
  
   
117
   
   
117
 
Equity securities
                
Growth
  
116,486
   
   
   
116,486
 
Value
  
36,356
   
   
   
36,356
 
Multi-asset and asset allocation
  
50,195
   
   
   
50,195
 
Other(1)
  
56,399
   
   
   
56,399
 
Fixed Income securities
                
Taxable(2)
  
146,730
   
2,968
   
   
149,698
 
Tax-exempt(3)
  
5,227
   
795
   
   
6,022
 
Derivatives
  
1,619
   
6,007
   
   
7,626
 
Long exchange-traded options
  
13,074
   
   
   
13,074
 
Private equity
  
5,229
   
19,221
   
61,426
   
85,876
 
Total assets measured at fair value
 
$
706,773
  
$
853,169
  
$
61,426
  
$
1,621,368
 
 
                
Securities sold not yet purchased
                
Short equities – corporate
 
$
37,769
  
$
  
$
  
$
37,769
 
Short exchange-traded options
  
15,065
   
   
   
15,065
 
Derivatives
  
70
   
1,208
   
   
1,278
 
Total liabilities measured at fair value
 
$
52,904
  
$
1,208
  
$
  
$
54,112
 
 
 
 
 
December 31, 2012
 
 
 
Level 1
  
Level 2
  
Level 3
  
Total
 
 
 
(in thousands)
 
 
        
Money markets
 
$
170,120
  
$
  
$
  
$
170,120
 
U.S. Treasury Bills
  
   
1,537,150
   
   
1,537,150
 
U.K. Treasury Bills
  
   
125
   
   
125
 
Equity securities
                
Growth
  
125,242
   
   
   
125,242
 
Value
  
36,126
   
   
   
36,126
 
Multi-asset and asset allocation
  
59,449
   
   
   
59,449
 
Other(1)
  
39,702
   
   
   
39,702
 
Fixed Income securities
                
Taxable(2)
  
177,635
   
1,219
   
   
178,854
 
Tax-exempt(3)
  
5,661
   
797
   
   
6,458
 
Derivatives
  
64
   
2,561
   
   
2,625
 
Long exchange-traded options
  
15,087
   
   
   
15,087
 
Private equity
  
7,695
   
   
76,953
   
84,648
 
Total assets measured at fair value
 
$
636,781
  
$
1,541,852
  
$
76,953
  
$
2,255,586
 
 
                
Securities sold not yet purchased
                
Short equities – corporate
 
$
54,370
  
$
  
$
  
$
54,370
 
Short exchange-traded options
  
9,197
   
   
   
9,197
 
Other
  
271
   
   
   
271
 
Derivatives
  
1,598
   
5,472
   
   
7,070
 
Total liabilities measured at fair value
 
$
65,436
  
$
5,472
  
$
  
$
70,908
 
 
(1)  Primarily corporate and government securities.
(2)  Primarily corporate and government securities.
(3)  Primarily municipal bonds.
Fair value measurement Level 3 reconciliation
The following table summarizes the change in carrying value associated with Level 3 financial instruments carried at fair value:

 
 
Three Months Ended June 30,
  
Six Months Ended June 30,
 
 
 
2013
  
2012
  
2013
  
2012
 
 
 
(in thousands)
 
 
        
Balance as of beginning of period
 
$
74,853
  
$
58,235
  
$
76,953
  
$
64,466
 
 
                
Transfers out
  
(19,220
)
  
   
(19,220
)
  
(13,548
)
Purchases
  
87
   
1,988
   
97
   
3,833
 
Sales
  
(34
)
  
(1,823
)
  
(34
)
  
(1,823
)
Realized gains (losses), net
  
(6,581
)
  
855
   
(6,581
)
  
855
 
Unrealized gains (losses), net
  
12,321
   
(1,347
)
  
10,211
   
4,125
 
Balance as of end of period
 
$
61,426
  
$
57,908
  
$
61,426
  
$
57,908
 
Information about Level 3 fair value measurements
The following table provides quantitative information about Level 3 fair value measurements:

 
Fair Value as of June 30, 2013
 
Valuation Technique
Unobservable Input
Range
 
 
(in thousands)
     
Private Equity:
 
 
 
 
 
 
 
 
 
Technology, Media and Telecommunications
 
$
23,256
 
Market comparable companies
Revenue multiple
  
2.5 – 6.0
 
 
    
          
Discount rate
  
18
%
 
    
          
Discount years
  
1.5
 
 
    
 
 
    
Healthcare and Cleantech
 
$
1,849
 
Market comparable companies
Revenue multiple(1)
  
0.7 – 62.5
 
 
    
          
R&D multiple(1)
  
1.0 – 32.4
 
 
    
          
Discount for lack of marketability and risk factors
  
50-60
%
                             
 (1)The median for the Healthcare and Cleantech revenue multiple is 8.4; the median R&D multiple is 5.2.